Nadia F. Altomare
"I am inspired by the innovation of Sera’s technology and I believe that we can lead the way to decrease the frequency and severity of preterm birth, and importantly, advocate for a new standard to detect premature birth early."
Nadia Altomare has more than 20 years of women’s healthcare experience and an extensive knowledge in developing and implementing strategic plans to drive commercial growth in the life sciences, biotechnology, and diagnostic industries. Ms. Altomare has held senior management positions in single and multi-product/service environments spanning from entrepreneurial to Fortune 500 companies.
Ms. Altomare served as chief executive officer of an early detection of cancer diagnostics company, Abcodia Limited, where she shaped the global commercial, regulatory and fundraising strategies for the business. In addition, she served as vice president and general manager of the DNA analysis business at ThermoFisher Scientific (formerly Life Technologies) and also held leadership roles at PerkinElmer, including as the vice president & general manager of the cytogenetic DNA testing and as vice president of commercial operations, where she integrated the ViaCord acquisition into the broader diagnostic unit.